The Current Ratio as of September 2024 (TTM) for BioLineRx Ltd. (BLRX) is 1.61

According to BioLineRx Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.61. This represents a change of 3.29% compared to the average of 1.56 of the last 4 quarters.

BioLineRx Ltd. (BLRX) Historical Current Ratio (quarterly & annually)

How has BLRX Current Ratio performed in the past?

The mean historical Current Ratio of BioLineRx Ltd. over the last ten years is 6.63. The current 1.61 Current Ratio has changed 2.33% with respect to the historical average. Over the past ten years (40 quarters), BLRX's Current Ratio was at its highest in in the March 2016 quarter at 17.92. The Current Ratio was at its lowest in in the March 2024 quarter at 1.14.

BioLineRx Ltd. (BLRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioLineRx Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioLineRx Ltd. (BLRX) Average Current Ratio

How has BLRX Current Ratio performed in the past?

The current Current Ratio of BioLineRx Ltd. (BLRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioLineRx Ltd. (BLRX) Current Ratio vs. Peers

How is BLRX’s Current Ratio compared to its peers?

BioLineRx Ltd.’s Current Ratio is less than Ardelyx, Inc. (4.21), less than Lexicon Pharmaceuticals, Inc. (11.51), greater than Seres Therapeutics, Inc. (1.38), less than ImmunityBio, Inc. (3.91), less than X4 Pharmaceuticals, Inc. (6.07), less than Mereo BioPharma Group plc (6.07), less than Inozyme Pharma, Inc. (9.84), less than Terns Pharmaceuticals, Inc. (21.02), less than Leap Therapeutics, Inc. (5.10), less than Verrica Pharmaceuticals Inc. (2.36), less than Verona Pharma plc (8.61), less than Galera Therapeutics, Inc. (5.63), less than Arcutis Biotherapeutics, Inc. (8.46), greater than Protalix BioTherapeutics, Inc. (1.33), less than Cidara Therapeutics, Inc. (4.25), greater than Fortress Biotech, Inc. (1.37), greater than Mustang Bio, Inc. (0.46), less than Achilles Therapeutics plc (8.24), greater than Aptose Biosciences Inc. (0.80), greater than Fortress Biotech, Inc. (1.37),

Build a custom stock screener for BioLineRx Ltd. (BLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioLineRx Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioLineRx Ltd. (BLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioLineRx Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.